It is also expressed at high levels on tumor-infiltrating regulatory T cells (Tregs) and antibodies targeting CTLA-4 can selectively deplete these cells by antibody-mediated cellular cytotoxicity (ADCC) mechanisms [23]. The gene discussed is CTLA4; the disease is neoplasm.